Filing Details
- Accession Number:
- 0001562180-21-005209
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-06 13:13:09
- Reporting Period:
- 2021-08-05
- Accepted Time:
- 2021-08-06 13:13:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1531048 | Inari Medical Inc. | NARI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1304099 | William Hoffman | C/O Inari Medical, Inc. 9 Parker, Suite 100 Irvine CA 92618 | President And Ceo | No | No | No | No |
Transaction Summary
| Sold: | 30,000 shares | Avg. Price: $93.33 | Total Value: $2,799,973.71 |
| Number of Shares After Transactions: | 730,831 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-05 | 2,700 | $92.58 | 758,131 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-05 | 17,253 | $93.08 | 740,878 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-05 | 10,047 | $93.96 | 730,831 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020.
- This transaction was executed in multiple trades at prices ranging from $91.76 to $92.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes 235 shares acquired on July 30, 2021 under the Employee Stock Purchase Plan since the reporting person's last Form 4 filing.
- This transaction was executed in multiple trades at prices ranging from $92.77 to $93.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $93.77 to $94.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
